Separation, structural determination and biological evaluation of the thymidylate synthase inhibitor 3,3-di-(4'- hydroxyphenyl)6(7)-chloro-1-oxo-1H,3H-naphtho[1,8-cd]pyran

Journal of Heterocyclic Chemistry

Volumn 36, Issue 4, 1999, Pages 1043-1048

  Costi, M Paola ^a   Tondi, Donatella ^a   Pecorari, Piergiorgio ^a   Rinaldi, Marcella ^a   Celentano, Giuseppe ^b   Ghelli, Stefano ^a   Antolini, Luciano ^a   Barlocco, Daniela ^b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3,3 BIS(4' HYDROXYPHENYL) 6(7) CHLORO 1 OXO 1H,3H NAPHTHO[1,8 CD]PYRAN; BACTERIAL ENZYME; THYMIDYLATE SYNTHASE; THYMIDYLATE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CRYSTAL STRUCTURE; DRUG ANALYSIS; DRUG DETERMINATION; DRUG SCREENING; ENZYME INHIBITION; LACTOBACILLUS CASEI; X RAY ANALYSIS;

EID: 0032836583     PISSN: 0022152X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jhet.5570360435     Document Type: Article

References (22)

1. C. W. Carreras and D. V. Santi, Annu. Rev. Biochem., 64, 721 (1995).
2. M. D. Varney, C. L. Palmer and J. G. Deal, (Agouron Pharmaceuticals, Inc., USA) PCT Int. Appl. WO96 02, 502 (Cl. C07D209/62), 1 Feb 1996, US Appl. 276,929, 19 Jul 1994, 44 pp.
3. A. Gangjee, F. Mavandadi, R. L. Kisluik, J. McGuire and S. F. Queener, J. Med. Chem., 39, 4563 (1996).
4. M. P. Costi, Med. Res. Rev., 18, 21 (1998).
5. S. Ghelli, G. Rastelli, D. Barlocco, D. Tondi, M. Rinaldi, P. G. Pecorari and M. P. Costi, Bioorg. Med. Chem., 4, 1783 (1996);
6. [b] One detailed papers on phthalein and naphthalene derivatives acting as thymidylate synthase inhibitors is meanwhile in press in J. Med. Chem., which describes their design, synthesis and biological evaluation. Many of these are positional isomers of compound 1 and were tested as isomeric mixtures, based on the observations made in the present paper.
7. I. D. Kuntz, Science, 257, 1078 (1992).
8. R. S. Bohacek, C. McMartin and W. C. Guida, Med. Res. Rev., 16, 3 (1996).
9. T. Stout, D. Tondi, M. Rinaldi, D. Barlocco, P. Pecorari, D. V. Santi, I. D. Kuntz, R. M. Stroud, B. K. Shoichet and M. P. Costi, Biochemistry, 38, 1607 (1999).
10. F. H. Allen, O. Kennard, D. G. Watson, L. Brammer, A. G. Orpen and R. J. Taylor, J. Chem. Soc., Perkin Trans. 2, S1 (1987).
11. T. E. Ferrin, C. C. Hauang, L. E. Jarvis and R. J. Langridge, J. Mol. Graphic, 6, 13 (1988).
12. R. E. Marsh, Acta Cryst., Sect. B. 42, 193 (1986).
13. G. M. Sheldrick, SHELX-86. Program for crystal structure solution; University of Gottingen, Germany, 1986.
14. G. M. Sheldrick, SHELX-93. Program for the refinement of crystal structures; University of Göttingen, Germany, 1993.
15. W. P. Aue, E. Batholdi and R. R. Ernst, J. Chem. Phys., 64, 2229 (1976).
16. J. Jeener, B. H. Meier, P. Bachmann and R .R. Ernst, J. Chem. Phys., 71, 4546 (1979).
17. G. Bodenhausen, R. L. Vold and R. R. Vold, J. Magn. Reson., 37, 93 (1980).
18. S. Climie and D. V. Santi, Proc. Natl. Acad. Sci. USA, 87, 633 (1990).
19. D. V. Santi, K. Pinter, J. Kealy and V. J. Davisson, J. Biol. Chem., 265, 6770 (1990).
20. I. H. Segel, in Enzyme Kinetics, J. Wiley and Sons, Inc., 1975, p 105.
21. Kaleidagraph 3.0, (Abelbeck, Software Reading, PA, 1989, version 2.3).
22. C. K. Johnson, ORTEP. Report ORNL-3794; Oak Ridge National Laboratory, Tennessee, 1965.